                               SEQUENCE LISTING

<110> HEALTHTELL INC.
 
<120> METHODS OF SELECTING FUNCTIONAL INTERFACE MIMICS, AND 
      COMPOSITIONS THEREOF

<130> 43638-728.601

<140> PCT/US2019/061196
<141> 2019-11-13

<150> 62/767,426
<151> 2018-11-14

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 50
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)...(50)
<223> This sequence may encompass 1-10 "Gly Gly Gly Gly Ser"
      repeating units 

<400> 1
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        35                  40                  45              


Gly Ser 
    50  


<210> 2
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(30)
<223> This sequence may encompass 1-10 "Gly Ser Gly"
      repeating units

<400> 2
Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly 
1               5                   10                  15      


Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly Gly Ser Gly 
            20                  25                  30  


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   


<210> 4
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gly Gly Gly Gly Ser Gly Gly Gly Ser 
1               5                   


<210> 5
<211> 40
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)...(40)
<223> This sequence may encompass 1-10 "Pro Gly Ser Gly"
      repeating units

<400> 5
Pro Gly Ser Gly Pro Gly Ser Gly Pro Gly Ser Gly Pro Gly Ser Gly 
1               5                   10                  15      


Pro Gly Ser Gly Pro Gly Ser Gly Pro Gly Ser Gly Pro Gly Ser Gly 
            20                  25                  30          


Pro Gly Ser Gly Pro Gly Ser Gly 
        35                  40  


<210> 6
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Pro Gly Ser Gly Ser Gly 
1               5      




